유방암 중심부 바늘 생검 시장 분석 및 예측 : 유형, 제품 유형, 기술, 용도, 기기, 프로세스, 최종 사용자, 기능, 설치 형태, 장비(-2035년)

The global Breast Cancer Core Needle Biopsy Market is projected to grow from $0.8 billion in 2025 to $1.8 billion by 2035, at a compound annual growth rate (CAGR) of 7.4%. The market is moderately consolidated, with vacuum-assisted biopsy systems leading adoption. It is driven by the increasing prevalence of breast cancer and demand for minimally invasive diagnostics. Hospitals and diagnostic centers are primary users. Innovation focuses on improving accuracy, precision, and patient comfort. Strategic collaborations with healthcare providers and research institutions support development. The market sees strong demand in developed regions with advanced healthcare infrastructure. Growing awareness of early cancer detection continues to drive adoption of biopsy technologies globally.

The Breast Cancer Core Needle Biopsy Market, by type, is led by vacuum-assisted core needle biopsy systems due to their ability to collect larger and more representative tissue samples, significantly improving diagnostic accuracy. These systems are widely preferred in minimally invasive procedures and outpatient settings, as they reduce procedure time, patient discomfort, and overall healthcare costs. Their growing adoption is supported by advancements in biopsy technologies and increasing awareness of early cancer detection. Meanwhile, fine needle aspiration remains a relevant subsegment, particularly in cost-sensitive settings and for preliminary screenings, although it offers comparatively limited diagnostic detail.

By technology, the market is dominated by ultrasound-guided biopsy techniques, driven by their real-time imaging capabilities and high precision in needle placement. These systems are widely used due to their safety, accessibility, and effectiveness in detecting both palpable and non-palpable lesions. The rising prevalence of breast cancer and growing emphasis on early and accurate diagnosis are key factors supporting this segmentas growth. Additionally, stereotactic-guided biopsy is gaining importance in complex cases requiring precise lesion localization, particularly for abnormalities detected through mammography, contributing to technological advancements in biopsy procedures.

Geographical Overview

The Breast Cancer Core Needle Biopsy market in North America is highly mature, supported by advanced healthcare infrastructure and widespread adoption of early cancer screening programs. The United States leads due to high awareness, strong presence of medical device manufacturers, and continuous advancements in imaging-guided biopsy technologies. Increasing prevalence of breast cancer and emphasis on early diagnosis further drive demand. Canada contributes through organized screening initiatives and improved access to diagnostic services. Technological innovation focused on minimally invasive procedures and patient comfort continues to enhance adoption across hospitals and diagnostic centers in the region.

The Asia-Pacific Breast Cancer Core Needle Biopsy market is experiencing rapid growth due to rising awareness of early cancer detection and improving healthcare infrastructure. Countries such as China and India are key contributors, driven by increasing cancer incidence and expanding diagnostic capabilities. Government initiatives promoting cancer screening programs and investments in healthcare facilities are supporting market expansion. Japan and South Korea also contribute with advanced medical technologies. Growing adoption of minimally invasive diagnostic procedures and increasing access to healthcare services are expected to sustain strong growth across the region in the coming years.

Key Trends and Drivers

Adoption of Minimally Invasive Procedures:

The breast cancer core needle biopsy market is experiencing a strong trend toward minimally invasive diagnostic procedures. Core needle biopsy is gaining popularity due to its ability to provide accurate results with reduced patient discomfort and shorter recovery times. Advances in imaging technologies are further enhancing the precision of these procedures, allowing better targeting of suspicious tissues. Healthcare providers are increasingly recommending minimally invasive techniques to improve patient outcomes and reduce procedural risks. As awareness of these benefits grows, the adoption of core needle biopsy is expected to increase significantly.

Rising Incidence of Breast Cancer:

The increasing global incidence of breast cancer is a major driver of the core needle biopsy market. As one of the most common cancers among women, the need for early and accurate diagnosis is critical. Core needle biopsy plays a vital role in confirming diagnoses and guiding treatment decisions. Growing awareness campaigns and screening programs are encouraging early detection, further boosting demand. Additionally, improvements in healthcare infrastructure and access to diagnostic services are supporting market growth. This rising disease burden continues to drive the need for reliable biopsy procedures worldwide.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Technology
• 2.4 Key Market Highlights by Application
• 2.5 Key Market Highlights by End User
• 2.6 Key Market Highlights by Process
• 2.7 Key Market Highlights by Device
• 2.8 Key Market Highlights by Functionality
• 2.9 Key Market Highlights by Installation Type
• 2.10 Key Market Highlights by Equipment

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Vacuum-Assisted Biopsy
  • 4.1.2 Fine Needle Aspiration Biopsy
  • 4.1.3 Core Needle Biopsy
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Biopsy Needles
  • 4.2.2 Biopsy Guns
  • 4.2.3 Biopsy Guidance Systems
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Technology (2020-2035)
  • 4.3.1 Ultrasound-Guided
  • 4.3.2 Stereotactic-Guided
  • 4.3.3 MRI-Guided
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Application (2020-2035)
  • 4.4.1 Breast Cancer Diagnosis
  • 4.4.2 Breast Cancer Screening
  • 4.4.3 Others
• 4.5 Market Size & Forecast by End User (2020-2035)
  • 4.5.1 Hospitals
  • 4.5.2 Diagnostic Centers
  • 4.5.3 Ambulatory Surgical Centers
  • 4.5.4 Others
• 4.6 Market Size & Forecast by Process (2020-2035)
  • 4.6.1 Image-Guided Biopsy
  • 4.6.2 Palpation-Guided Biopsy
  • 4.6.3 Others
• 4.7 Market Size & Forecast by Device (2020-2035)
  • 4.7.1 Handheld Devices
  • 4.7.2 Automated Devices
  • 4.7.3 Others
• 4.8 Market Size & Forecast by Functionality (2020-2035)
  • 4.8.1 Disposable
  • 4.8.2 Reusable
  • 4.8.3 Others
• 4.9 Market Size & Forecast by Installation Type (2020-2035)
  • 4.9.1 Portable
  • 4.9.2 Fixed
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Equipment (2020-2035)
  • 4.10.1 Biopsy Tables
  • 4.10.2 Imaging Equipment
  • 4.10.3 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Technology
    • 5.2.1.4 Application
    • 5.2.1.5 End User
    • 5.2.1.6 Process
    • 5.2.1.7 Device
    • 5.2.1.8 Functionality
    • 5.2.1.9 Installation Type
    • 5.2.1.10 Equipment
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Technology
    • 5.2.2.4 Application
    • 5.2.2.5 End User
    • 5.2.2.6 Process
    • 5.2.2.7 Device
    • 5.2.2.8 Functionality
    • 5.2.2.9 Installation Type
    • 5.2.2.10 Equipment
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Technology
    • 5.2.3.4 Application
    • 5.2.3.5 End User
    • 5.2.3.6 Process
    • 5.2.3.7 Device
    • 5.2.3.8 Functionality
    • 5.2.3.9 Installation Type
    • 5.2.3.10 Equipment
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Technology
    • 5.3.1.4 Application
    • 5.3.1.5 End User
    • 5.3.1.6 Process
    • 5.3.1.7 Device
    • 5.3.1.8 Functionality
    • 5.3.1.9 Installation Type
    • 5.3.1.10 Equipment
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Technology
    • 5.3.2.4 Application
    • 5.3.2.5 End User
    • 5.3.2.6 Process
    • 5.3.2.7 Device
    • 5.3.2.8 Functionality
    • 5.3.2.9 Installation Type
    • 5.3.2.10 Equipment
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Technology
    • 5.3.3.4 Application
    • 5.3.3.5 End User
    • 5.3.3.6 Process
    • 5.3.3.7 Device
    • 5.3.3.8 Functionality
    • 5.3.3.9 Installation Type
    • 5.3.3.10 Equipment
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Technology
    • 5.4.1.4 Application
    • 5.4.1.5 End User
    • 5.4.1.6 Process
    • 5.4.1.7 Device
    • 5.4.1.8 Functionality
    • 5.4.1.9 Installation Type
    • 5.4.1.10 Equipment
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Technology
    • 5.4.2.4 Application
    • 5.4.2.5 End User
    • 5.4.2.6 Process
    • 5.4.2.7 Device
    • 5.4.2.8 Functionality
    • 5.4.2.9 Installation Type
    • 5.4.2.10 Equipment
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Technology
    • 5.4.3.4 Application
    • 5.4.3.5 End User
    • 5.4.3.6 Process
    • 5.4.3.7 Device
    • 5.4.3.8 Functionality
    • 5.4.3.9 Installation Type
    • 5.4.3.10 Equipment
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Technology
    • 5.4.4.4 Application
    • 5.4.4.5 End User
    • 5.4.4.6 Process
    • 5.4.4.7 Device
    • 5.4.4.8 Functionality
    • 5.4.4.9 Installation Type
    • 5.4.4.10 Equipment
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Technology
    • 5.4.5.4 Application
    • 5.4.5.5 End User
    • 5.4.5.6 Process
    • 5.4.5.7 Device
    • 5.4.5.8 Functionality
    • 5.4.5.9 Installation Type
    • 5.4.5.10 Equipment
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Technology
    • 5.4.6.4 Application
    • 5.4.6.5 End User
    • 5.4.6.6 Process
    • 5.4.6.7 Device
    • 5.4.6.8 Functionality
    • 5.4.6.9 Installation Type
    • 5.4.6.10 Equipment
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Technology
    • 5.4.7.4 Application
    • 5.4.7.5 End User
    • 5.4.7.6 Process
    • 5.4.7.7 Device
    • 5.4.7.8 Functionality
    • 5.4.7.9 Installation Type
    • 5.4.7.10 Equipment
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Technology
    • 5.5.1.4 Application
    • 5.5.1.5 End User
    • 5.5.1.6 Process
    • 5.5.1.7 Device
    • 5.5.1.8 Functionality
    • 5.5.1.9 Installation Type
    • 5.5.1.10 Equipment
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Technology
    • 5.5.2.4 Application
    • 5.5.2.5 End User
    • 5.5.2.6 Process
    • 5.5.2.7 Device
    • 5.5.2.8 Functionality
    • 5.5.2.9 Installation Type
    • 5.5.2.10 Equipment
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Technology
    • 5.5.3.4 Application
    • 5.5.3.5 End User
    • 5.5.3.6 Process
    • 5.5.3.7 Device
    • 5.5.3.8 Functionality
    • 5.5.3.9 Installation Type
    • 5.5.3.10 Equipment
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Technology
    • 5.5.4.4 Application
    • 5.5.4.5 End User
    • 5.5.4.6 Process
    • 5.5.4.7 Device
    • 5.5.4.8 Functionality
    • 5.5.4.9 Installation Type
    • 5.5.4.10 Equipment
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Technology
    • 5.5.5.4 Application
    • 5.5.5.5 End User
    • 5.5.5.6 Process
    • 5.5.5.7 Device
    • 5.5.5.8 Functionality
    • 5.5.5.9 Installation Type
    • 5.5.5.10 Equipment
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Technology
    • 5.5.6.4 Application
    • 5.5.6.5 End User
    • 5.5.6.6 Process
    • 5.5.6.7 Device
    • 5.5.6.8 Functionality
    • 5.5.6.9 Installation Type
    • 5.5.6.10 Equipment
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Technology
    • 5.6.1.4 Application
    • 5.6.1.5 End User
    • 5.6.1.6 Process
    • 5.6.1.7 Device
    • 5.6.1.8 Functionality
    • 5.6.1.9 Installation Type
    • 5.6.1.10 Equipment
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Technology
    • 5.6.2.4 Application
    • 5.6.2.5 End User
    • 5.6.2.6 Process
    • 5.6.2.7 Device
    • 5.6.2.8 Functionality
    • 5.6.2.9 Installation Type
    • 5.6.2.10 Equipment
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Technology
    • 5.6.3.4 Application
    • 5.6.3.5 End User
    • 5.6.3.6 Process
    • 5.6.3.7 Device
    • 5.6.3.8 Functionality
    • 5.6.3.9 Installation Type
    • 5.6.3.10 Equipment
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Technology
    • 5.6.4.4 Application
    • 5.6.4.5 End User
    • 5.6.4.6 Process
    • 5.6.4.7 Device
    • 5.6.4.8 Functionality
    • 5.6.4.9 Installation Type
    • 5.6.4.10 Equipment
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Technology
    • 5.6.5.4 Application
    • 5.6.5.5 End User
    • 5.6.5.6 Process
    • 5.6.5.7 Device
    • 5.6.5.8 Functionality
    • 5.6.5.9 Installation Type
    • 5.6.5.10 Equipment

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Hologic
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Becton Dickinson
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Leica Biosystems
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 Argon Medical Devices
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Cook Medical
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Devicor Medical Products
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 C. R. Bard
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Fujifilm Holdings
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 Boston Scientific
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Siemens Healthineers
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Medtronic
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Cardinal Health
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Merit Medical Systems
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Danaher Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 Thermo Fisher Scientific
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Johnson & Johnson
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Koninklijke Philips
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Stryker Corporation
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 GE Healthcare
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Abbott Laboratories
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us